help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on March 15, 2007, doi:10.1165/rcmb.2007-0066TR
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0066TRv1
37/1/31    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sehgal, P. B.
Right arrow Articles by Mukhopadhyay, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sehgal, P. B.
Right arrow Articles by Mukhopadhyay, S.
American Journal of Respiratory Cell and Molecular Biology. Vol. 37, pp. 31-37, 2007
© 2007 American Thoracic Society
DOI: 10.1165/rcmb.2007-0066TR


Translational Review

Dysfunctional Intracellular Trafficking in the Pathobiology of Pulmonary Arterial Hypertension

Pravin B. Sehgal and Somshuvra Mukhopadhyay

Departments of Cell Biology & Anatomy and of Medicine, New York Medical College, Valhalla, New York

Correspondence and requests for reprints should be addressed to Dr. Pravin B. Sehgal, Rm. 201, Basic Sciences Building, Department of Cell Biology & Anatomy, New York Medical College, Valhalla, NY 10595. E-mail: pravin_sehgal{at}nymc.edu

Discussions of the initiation of pulmonary arterial hypertension (PAH) in man and in experimental models have centered around intimal and medial proliferation in medium-sized pulmonary arteries. The histologic events are thought to include disordered proliferation of enlarged, vacuolated endothelial cells, neo-muscularization of the affected blood vessels, and vascular pruning. The discovery of the association of familial and sporadic PAH with mutations in BMPR2 has generated intense interest in cytokine receptor trafficking and function in the endothelial cell and how this might be disrupted to yield an enlarged proliferative cell phenotype. Nevertheless, considerations of the subcellular machinery of membrane trafficking in the endothelial cell and consequences of the disruption of this outward and inward membrane trafficking are largely absent from discussions of the pathobiology of PAH. Long-standing electron microscopy data in the PAH field has demonstrated marked disruptions of intracellular membrane trafficking in human and experimental PAH. Further, a role of the membrane-trafficking regulator Nef in simian HIV-induced PAH in macaques and in HIV-induced PAH in man is now evident. Additionally, monocrotaline and hypoxia are known to disrupt the function of Golgi tethers, SNAREs, SNAPs, and N-ethylmaleimide–sensitive factor ("the Golgi blockade hypothesis"). These results, along with recent reports demonstrating the trapping of PAH-associated human BMPR2 mutants in the Golgi, highlight the implications of disrupted intracellular membrane trafficking in the pathobiology of PAH. The purpose of this review is to present a brief overview of the molecular basis of intracellular trafficking and relate these considerations to the pathobiology of PAH.

Key Words: pulmonary hypertension • endothelium • Golgi organelle • vesicular trafficking


CLINICAL RELEVANCE

This review highlights an altogether novel way of thinking about the pathobiology of pulmonary arterial hypertension. We posit that the underlying pathogenesis, irrespective of etiology, is related to a disruption of intracellular trafficking.

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.
  ATS Best of the Web